NAVLIN Price & Access Software

NAVLIN Price & Access Software offers a comprehensive solution for pharmaceutical manufacturers to tackle global pricing challenges. It integrates existing price and access data to manage global pricing strategies effectively.

The software supports Launch Sequence Optimization by optimizing pricing throughout the launch cycle and understanding its impacts across different markets. It also provides International Reference Pricing (IRP) capabilities, including advanced features like Monte Carlo simulation and breakeven analysis for product and portfolio price forecasting.

Contract & Tender Management is facilitated through the full lifecycle, from discovery and pricing to compliance. The software also offers Gross-to-Net Analysis to evaluate net prices and forecast pricing impacts.

With Price Certificates & Compliance, users can monitor price accuracy, generate certificates, and manage drug transparency reporting. The software also includes Market Access & KPI Tracking for benchmarking key performance indicators in pricing and market access.

AI-supported Loss of Exclusivity (LOE) Forecasting accelerates early analysis and identifies comparator behavior, while Predictive Tender Pricing uses AI to forecast tender pricing. Users can create Launch Analogues & Benchmarks to simulate launch scenarios and compare against competitors.

Additional features include Launch Confidence for optimizing country sequencing and benchmarking launches, and Smarter, Faster Pricing to forecast entire portfolios, run multi-variable scenarios, and predict patent expiry impacts.

• Track and shape tender criteria with visibility into upcoming tenders.
• Model discounts with easy-to-set terms and analyze contract pricing.
• Flag price discrepancies and automatically generate local price certificates.

Overall, NAVLIN Price & Access Software provides a robust framework for managing pharmaceutical pricing with precision and compliance across global markets.